LFMD LifeMD, Inc.
LFMD LifeMD, Inc.
Healthcare · Health Information Services
Market read
POC $3.47 · VWAP $3.95 · -40.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
LFMD Price Structure
Loading timeframes…
Peers
Every watchlist LFMD belongs to, members best 30-day change first — LFMD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@peptide-economy
Reported the quarter ending 2026-06-30: revenue $47M, diluted EPS -$0.16, net income -$7M (SEC filing). Across the print the stock moved -12.8% (close before → first close after).
full note →Against street estimates
How LFMD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about LFMD from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 32 days ago · Sep 15
- LFMD: LifeMD Inc - Stock Price, Quote and News - CNBC
- LifeMD Earnings & Forecasts - Benzinga
- LifeMD (LFMD) Earnings Date and Reports 2026 $LFMD
- Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts By Investing.com
- LifeMD (LFMD) Investor Relations, Earnings Summary & Outlook
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LFMD research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.